Evaluation of Tiotropium 5 µg/Day Delivered Via the Respimat® Inhaler Over 48 Weeks in Patients With Severe Persistent Asthma on Top of Usual Care (Study II)
Clinical trial NCT00776984 · COMPLETED
Trial details
- NCT number
- NCT00776984
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2008-10-01
- Primary completion
- 2011-07-01
- Enrollment
- 453
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.